[Diagnosis of minimal breast cancer by diagnostic hormonal treatment].
After diagnostic hormonal treatment of 129 patients, 11 (8.5%) were revealed to have breast cancer. The diagnostic accuracy in the case of a lesion of less than 1.0 cm in diameter was 11.8% for palpation, 18.2% for mammography, 33.3% for ultrasonography; the accuracy of this method is 66.6%. Minimal breast cancer was present in eight out of nine cases. Thus, diagnostic hormonal treatment was found to be useful in the diagnosis of minimal breast cancer that coexists with mastopathy.
D000328:Adult; D000732:Androstanols / Q000031:analogs & derivatives*; D001940:Breast; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000473:pathology; D005260:Female; D005348:Fibrocystic Breast Disease / Q000175:diagnosis / Q000473:pathology; D005467:Floxuridine / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology; D006801:Humans; D008327:Mammography; D010173:Palpation; D014463:Ultrasonography
D000732:Androstanols; D005467:Floxuridine; C100263:dromostanolone; C049311:FF 707; C007561:dromostanolone propionate